Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission

Neurobiology of Disease

Volumn 37, Issue 3, 2010, Pages 641-655

  Bambico, Francis Rodriguez ^a   Nguyen, Nhu Tram ^a   Katz, Noam ^a   Gobbi, Gabriella ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Adolescence; Anxiety; Cannabinoids; Depression; Norepinephrine; Serotonin

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; DIAZEPAM; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; COPING BEHAVIOR; ELECTROPHYSIOLOGY; EMOTION; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED SWIMMING TEST; HYPERACTIVITY; MAZE TEST; MONOAMINE NERVE CELL; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

AGE FACTORS; AGING; ANIMALS; ANIMALS, NEWBORN; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; BENZOXAZINES; BIOGENIC MONOAMINES; BRAIN; BRAIN CHEMISTRY; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EMOTIONS; MALE; MARIJUANA ABUSE; MENTAL DISORDERS; MORPHOLINES; NAPHTHALENES; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SYNAPTIC TRANSMISSION; TIME;

EID: 75949092239     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.11.020     Document Type: Article

References (86)

1. Aghajanian G.K., Wang R.Y., and Baraban J. Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res. 153 (1978) 169-175
2. Allers K.A., and Sharp T. Neurochemical and anatomical identification of fast and slow-firing neurons in the ray dorsal raphe nucleus using juxtacellular labeling methods in vivo. Neuroscience 122 (2003) 193-204
3. 1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Exp.Opin.Ther. Targets 12 (2008) 1347-1366
4. Bambico F.R., Katz N., Debonnel G., and Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 27 (2007) 11700-11711
5. Bambico F.R., Duranti A., Tontini A., Tarzia G., and Gobbi G. Endocannabinoids in the treatment of mood disorders: evidence from animal models. Curr. Pharm. Des. 15 (2009) 1623-1646
6. 1A autoreceptors after chronic unpredictable stress. Eur. Neuropsychopharmacol. 19 3 (2009) 215-228
7. Baraban J.M., and Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19 4 (1980) 355-363
8. 35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J. Biol. Chem. 273 (1998) 16865-16873
9. Belue R.C., Howlett A.C., Westlake T.M., and Hutchings D.E. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol 17 (1995) 25-30
10. Bessa, J.M., Mesquita, A.R., Oliveira, M., Pêgo, J.M., Cerqueira, J.J., Palha, J.A., Almeida, O.F., Sousa, N., 2009. A trans-dimensional approach to the behavioural aspects of depression. Front. Behav. Neurosci. 3, 1.
11. Bielajew C., Konkle A.T.M., Kentner A.C., Baker S.L., Stewart A., Hutchins A.A., Barbagallo L.S.M., and Fouriezos G. Strain and gender specific effects in the forced swim test: effects of previous stress exposure. Stress-Int. J. Biol. Stress 6 (2003) 269-280
12. Biscaia M., Marin S., Fernandez B., Marco E.M., Rubio M., Guaza C., Ambrosio E., and Viveros M.P. Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood. Psychopharmacology 170 (2003) 301-308
13. Bodnoff S.R., Suranyicadotte B., Aitken D.H., Quirion R., and Meaney M.J. The effects of chronic antidepressant treatment in an animal-model of anxiety. Psychopharmacology 95 (1988) 298-302
14. Buchanan C.M., Eccles J.S., and Becker J.B. Are adolescents the victims of raging hormones-evidence for activational effects of hormones on moods and behavior at adolescence. Psychol. Bull. 111 (1992) 62-107
15. Chen X., and Herbert J. Regional changes in C-Fos expression in the basal forebrain and brain-stem during adaptation to repeated stress-correlations with cardiovascular, hypothermic and endocrine responses. Neuroscience 64 (1995) 675-685
16. Choleris E., Thomas A.W., Kavaliers M., and Prato F.S. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci. Biobehav. Rev. 25 (2001) 235-260
17. Cole J.C., and Rodgers R.J. Ethological comparison of the effects of diazepam and acute chronic imipramine on the behavior of mice in the elevated plus-maze. Pharmacol. Biochem. Behav 52 (1995) 473-478
18. Crespi, F., 2009. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety. J. Neurosci. Methods 180 (1), 97-105.
19. Cryan J.F., Hoyer D., and Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol. Psychiatry 54 (2003) 49-58
20. Deas D. Adolescent substance abuse and psychiatric comorbidities. J. Clin. Psychiatry 67 (2006) 18-23
21. Doremus-Fitzwater T.L., Varlinskaya E.I., and Spear L.P. Social and non-social anxiety in adolescent and adult rats after repeated restraint. Physiol. Behav 97 3-4 (2009) 484-494
22. Ellgren M., Artmann A., Tkalych O., Gupta A., Hansen H.S., Hansen S.H., Devi L.A., and Hurd Y.L. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur. Neuropsychopharmacol 18 (2008) 826-834
23. 1 receptors and fatty acid amide hydrolase in rat and mouse brain. Eur. J. Neurosci 12 (2000) 68
24. Finlay J.M., Jedema H.P., Rabinovic A.D., Mana M.J., Zigmond M.J., and Sved A.F. Impact of corticotropin-releasing hormone on extracellular norepinephrine in prefrontal cortex after chronic cold stress. J. Neurochem. 69 (1997) 144-150
25. 1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J. Pharmacol. Exp. Ther. 278 (1996) 752-762
26. 1A receptor antagonist, WAY 100,635. Eur. J. Pharmacol 281 (1994) 81-88
27. 1A receptors antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115 (1995) 1064-1070
28. Giedd J.N. Structural magnetic resonance imaging of the adolescent brain. Adolesc. Brain Dev. Vulnerabilities Opportunities 1021 (2004) 77-85
29. Giuliani D., Ferrari F., and Ottani A. The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress. Pharmacol. Res. 41 (2000) 47-53
30. Gobbi G., Murphy D.L., Lesch K., and Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J. Pharmacol. Exp. Ther. 296 3 (2001) 987-995
31. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., and Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18620-18625
32. Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons. J. Neurosci. 4 (1984) 2877-2890
33. 1A receptor KO mice. Biol. Psychiatry 48 (2000) 1157-1163
34. Haddjeri N., Lavoie N., and Blier P. Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus. Neuropsychopharmacology 29 10 (2004) 1800-1806
35. 1 receptors. J. Pharmacol. Exp. Ther. 331 1 (2009) 186-196
36. Haring M., Marsicano G., Lutz B., and Monory K. Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 146 (2007) 1212-1219
37. Harkany T., Keimpema E., Barabas K., and Mulder J. Endocannabinoid functions controlling neuronal specification during brain development. Mol. Cell. Endocrinol. 286 (2008) S84-S90
38. Hayatbakhsh M.R., Najman J.M., Jamrozik K., Mamun A.A., Alati R., and Bor W. Cannabis and anxiety and depression in young adults: a large prospective study. J. Am. Acad. Child Adolesc. Psychiatry 46 (2007) 408-417
39. Henquet C., Rosa A., Krabbendam L., Papiol S., Fananas L., Drukker M., Ramaekers J.G., and van Os J. An experimental study of catechol-O-methyltransferase Val158.Met moderation of Delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 31 (2006) 2748-2757
40. Higuera-Matas, A., Botreau, F., Miguéns, M., Del Olmo, N., Borcel, E., Pérez-Alvarez, L., García-Lecumberri, C., Ambrosio, E., 2009. Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory. Pharmacol. Biochem. Behav. 93 (4), 482-490.
41. Hoffman A.F., Oz M., Yang R.Q., Lichtman A.H., and Lupica C.R. Opposing actions of chronic Delta 9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn. Mem 14 (2007) 63-74
42. Howlett A.C., Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., and Porrino L.J. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 (2004) 345-358
43. Jentsch J.D., Andrusiak E., Tran A., Bowers Jr. M.B., and Roth R.H. Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology 16 6 (1997) 426-432
44. Juhasz G., Chase D., Pegg E., Downey D., Toth Z.G., Stones K., Platt H., Mekli K., Payton A., Elliott R., Anderson I.M., and Deakin J.F. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 34 8 (2009) 2019-2027
45. Kang-Park M.H., Wilson W.A., Kuhn C.M., Moore S.D., and Swartzwelder H.S. Differential sensitivity of GABA(A) receptor-mediated IPSCs to cannabinoids in hippocampal slices from adolescent and adult rats. J. Neurophysiol. 98 (2007) 1223-1230
46. König, M., Zimmer, A.M., Steiner, H., Holmes, P.V., Crawley, J.N., Brownstein, M.J., Zimmer, A., 1996. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383, 535-538.
47. Lazary J., Lazary A., Gonda X., Benko A., Molnar E., Hunyady L., Juhasz G., and Bagdy G. Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with the 5-HTTLPR affect the anxious phenotype. Am. J. Med. Genet. Part B, Neuropsychiatr. Genet. (2009) 150B (8), 1118-1127
48. Lin, H.C., Mao, S.C., Gean, P.W., 2006. Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle. Lean. Mem. 13 (3), 316-321.
49. Llorente R., Arranz L., Marco E.M., Moreno E., Puerto M., Guaza C., De la Fuente M., and Viveros M.P. Early maternal deprivation and neonatal single administration with a cannabinoid agonist induce long-term sex-dependent psychoimmunoendocrine effects in adolescent rats. Psychoneuroendocrinology 32 (2007) 636-650
50. Marco, E.M., Rubino, T., Adriani, W., Viveros, M.P., Parolaro, D., Laviola, G., 2009. Brain Res. 1257, 25-31.
51. Martin, L.P., Jackson, D.M., Wallsten, C., Waszczak, B.L., 1999. Electrophysiological comparison of 5-hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing. J. Pharmacol. Exp. Ther. 288 (2), 820-826.
52. Martín-Ruiz R., and Ugedo L. Electrophysiological evidence for postsynaptic 5-HT(1A) receptor control of dorsal raphe 5-HT neurones. Neuropharmacology 41 1 (2001) 72-78
53. Mathews I.Z., Wilton A., Styles A., and McCormick C.M. Increased depressive behaviour in females and heightened corticosterone release in males to swim stress after adolescent social stress in rats. Behav Brain Res. 190 1 (2008) 33-40
54. Mato, S., Chevaleyre, V., Robbe, D., Pazos, A., Castillo, P.E., Manzoni, O.J., 2004. A single in-vivo exposure to delta9THC blocks endocannabinoid-mediated synaptic plasticity. Nat. Neurosci. 7 (6), 585-586.
55. Muntoni A.L., Pillolla G., Melis M., Perra S., Gessa G.L., and Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur. J. Neurosci. 23 (2006) 2385-2394
56. O'Shea M., Singh M.E., McGregor I.S., and Mallet P.E. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J. Psychopharmacol. 18 (2004) 502
57. O'Shea M., McGregor I.S., and Mallet P.E. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar long-lasting deficits in object recognition and reduced social interaction in rats. J. Psychopharmacol. 20 (2006) 611-621
58. Oropeza V.C., Page M.E., and Van Bockstaele E.J. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Res. 1046 (2005) 45-54
59. Oropeza V.C., Mackie K., and Van Bockstaele E.J. Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res. 1127 (2007) 36-44
60. Page M.E., Oropeza V.C., Sparks S.E., Qian Y., Menko A.S., and Van Bockstaele E.J. Repeated cannabinoid administration increases indices of noradrenergic activity in rats. Pharmacol. Biochem. Behav. 86 (2007) 162-168
61. Palazzo E., de Novellis V., Petrosino S., Marabese I., Vita D., Giordano C., Di Marzo V., Mangoni G.S., Rossi F., and Maione S. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. Eur. J. Neurosci. 24 (2006) 2011-2020
62. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 6th ed. (2007), Elsevier/Academic Press, New York
63. 2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin. Br. J. Pharmacol. 153 (2008) 199-215
64. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., and Carlezon W.A. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 21 18 (2001) 7397-7403
65. Porsolt R.D., Lepichon M., and Jalfre M. Depression-new animal-model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
66. Quinn H.R., Matsumoto I., Callaghan P.D., Long L.E., Arnold J.C., Gunasekaran N., Thompson M.R., Dawson B., Mallet P.E., Kashem M.A., Matsuda-Matsumoto H., Iwazaki T., and McGregor I.S. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology 33 (2008) 1113-1126
67. Rodgers R.J., Cole J.C., Aboualfa K., and Stephenson L.H. Ethopharmacological analysis of the effects of putative anxiogenic agents in the mouse elevated plus-maze. Pharmacol. Biochem. Behav. 52 (1995) 805-813
68. Rubino T., Vigano D., Realini N., Guidali C., Braida D., Capurro V., Castiglioni C., Cherubino F., Romualdi P., Candeletti S., Sala M., and Parolaro D. Chronic Delta(9)-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 33 (2008) 2760-2771
69. Sagredo O., Ramos J.A., Fernandez-Ruiz J., Rodriguez M.L., and de Miguel R. Chronic Delta9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 372 (2006) 313-317
70. Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict. Biol. 13 (2008) 253-263
71. Schneider M., and Koch M. Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: Effects of chronic pubertal cannabinoid treatment. Neuropsychopharmacology 30 (2005) 944-957
72. Schramm-Sapyta N.L., Cha Y.M., Chaudhry S., Wilson W.A., Swartzwelder H.S., and Kuhn C.M. Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. Psychopharmacology 191 (2007) 867-877
73. Simson P.E., and Weiss J.M. Altered activity of the locus coeruleus in an animal model of depression. Neuropsychopharmacology 1 4 (1988) 287-295
74. Skrebuhhova T., Allikmets L., and Matto V. Effects of anxiogenic drugs in rat forced swimming test. Methods Find. Exp. Clin. Pharmacol. 21 (1999) 173-178
75. Smith R.J., and Aston-Jones G. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct. Funct 213 (2008) 43-61
76. Sousa, N., Almeida, O.F., Wotjak, C.T., 2006. A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes Brain Behav. 5, 5-24.
77. Spear L.P. Neurobehavioral changes in adolescence. Curr. Dir. Psychol. Sci 9 (2000) 111-114
78. Szabo S.T., Gold M.S., Goldberger B.A., and Blier P. Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons. Biol. Psychiatry 55 9 (2004) 934-939
79. Tanaka M., Yoshida M., Emoto H., and Ishii H. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur. J. Pharmacol 405 (2000) 397-406
80. Urbain N., Creamer K., and Debonnel G. Electrophysiological diversity of the dorsal raphe cells across the sleep-wake cycle of the rat. J. Physiol. 573 Pt 3 (2006) 679-695
81. Vandermaelen C.P., and Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res 289 (1983) 109-119
82. Walf A.A., and Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2 (2007) 322-328
83. Wegener, N., Koch, M., 2009. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment. Brain Res. 1253, 81-91.
84. Willner P. Animal-models of depression-an overview. Pharmacol. Ther. 45 (1990) 425-455
85. Wintink, A.J., Young, N.A., Davis, A.C., Gregus, A., Kalynchuk, L.E., 2003. Kindling-induced emotional behaviour in male and female rats. Behav. Neurosci. 117(3), 632-640.
86. Wittchen H.U., Frohlich C., Behrendt S., Gunther A., Rehm J., Zimmermann P., Lieb R., and Perkonigg A. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend. 88 (2007) S60-S70